John B. Beckman

John B. Beckman

Partner Corporate & Finance

Washington, D.C.

+1 202 637 5464

[email protected]

John B. Beckman

Overview
Experience
Credentials
Insights and events

'John Beckman is one of a kind. ... He is steady and builds trust and confidence with all management and our board.'
Client quoted in Legal 500 US 2021

John Beckman helps his clients navigate the ever-changing public company landscape. He focuses on SEC disclosure, financial and accounting issues, proxy solicitations, insider trading, state corporate law issues, strategic transactions, and corporate governance.

As the leader of the firm's U.S. Securities and Public Company Advisory practice, John's focus is on representing public companies and their boards on their most important matters. John frequently represents public companies and boards of directors on strategic transactions, including strategic review processes and unsolicited takeover proposals, financial restatements, and shareholder interactions, including shareholder engagement and proxy contests. He has over 20 years of experience advising clients on a broad range of complex transactions, such as mergers, acquisitions, tender offers, divestitures, spin-offs, dividends and distributions, capital markets financings and recapitalizations.

John serves as regular outside securities and corporate governance counsel to numerous NYSE and NASDAQ listed companies. In addition, John is regularly engaged as special counsel by other law firms, companies, and boards to advise on corporate governance matters, crises, and special situations.

John is nationally recognized as a leading lawyer in corporate governance and public company representations.

'John Beckman is uniquely expert in everything from the largest complex transaction to the most delicate matters of corporate governance. His advice is always practical and timely.'
Client quoted in Legal 500 US 2023

Representative experience

Bristol-Myers Squibb Co. (NYSE: BMY) on its tender offer and redemption of up to US$4bn of notes.

BWX Technologies Inc. (NYSE: BWXT) on its US$400m Rule 144A/Reg S unsecured notes offering.

Papa John's International (NASDAQ: PZZA) and its independent directors in a feud with its founder and US$250m investment by Starboard Value LP, named The Deal's Activist Campaign of the Year.

FLIR Systems Inc. (NASDAQ: FLIR) on its US$8bn sale to Teledyne Technologies Incorporated (NYSE: TDY) in a cash and stock merger transaction.

Equifax Inc. (NYSE: EFX) in connection with its corporate governance and securities matters, including an aggregate of US$3.75bn notes offerings following a cyber security incident.

Orbital ATK Inc. (NYSE: OA) on corporate governance, securities, and transactional matters, including a multi-year financial restatement and US$9.2bn sale to Northrop Grumman Corp. (NYSE: NOC).

Orbital Sciences Corp. (NYSE: ORB) in connection with its US$5bn "merger of equals" transaction with Alliant Techsystems Inc.

Reliance Steel & Aluminum Co. (NYSE: RS) on its corporate governance and securities matters, including its reincorporation from California to Delaware and US$900m investment grade bond offering.

McCormick & Co. (NYSE: MKC), a global leader in flavor and spices, in its debt offerings.

Choice Hotels International Inc. (NYSE: CHH) in connection with its corporate governance and securities matters, including an aggregate of US$850m debt offering and special dividend transaction.

Osiris Therapeutics Inc. (NASDAQ: OSIR) in a multi-year financial restatement and its subsequent sale by tender offer to Smith & Nephew PLC.